Introduction {#s1}
============

Wilms tumour 1 (WT1) is a zinc finger transcription factor that regulates key developmental stages of several mesodermal tissues including the kidneys, gonads and coronary vasculature ([@bib20]). In the developing kidney, WT1 is required for the maintenance of mesenchymal nephron progenitors ([@bib29]; [@bib40]) as well as differentiation of these progenitors into the epithelial components of the nephron ([@bib14]). In contrast, in the developing heart, WT1 is expressed in the epicardium (mesothelial lining) and required for the production, via an epithelial to mesenchymal transition (EMT), of coronary vascular progenitors (EPDCs) that migrate into the myocardium ([@bib36]). Similarly, WT1-expressing mesothelium is the source of mesenchymal progenitors for specialised cell types within several other developing organs. These include stellate cells within the liver ([@bib2]), interstitial cells of Cajal in the intestine ([@bib6]) and adipocytes within visceral fat depots ([@bib7]). WT1 expression is down-regulated in the epicardium postnatally but reactivated in response to tissue damage in both mice ([@bib50]) and zebrafish ([@bib48]). In both organisms, this activation of WT1 in response to damage is associated with new rounds of epicardial EMT, leading to the production of coronary vascular progenitors ([@bib48]; [@bib50]).

Given the reactivation of *Wt1/wt1b* in the damaged epicardium we set out to investigate whether Wt1 programmes are initiated in response to other sources of tissue damage in zebrafish, and uncovered a novel Wt1 response to wounding of the notochord. The notochord is a transient embryonic structure that provides axial support and signalling information ([@bib51]). The notochord comprises two cell populations, the inner vacuolated cells that provide rigid support to the embryo, and the outer sheath cells, a single cell epithelial layer that surrounds the vacuolated cells and secretes components of the extracellular matrix to provide turgor pressure to the vacuolated cells ([@bib1]; [@bib12]). This rigid axial structure becomes functionally replaced by vertebra of the axial skeleton over time. In zebrafish, a row of metameric mineralized rings, known as chordacentra, forms around the notochord in an anterior to posterior fashion and constitutes the first signs of the definitive vertebral column. The chordacentra delineate the future sites where mature vertebra will form and ossify as the larva grows, while the notochord cells develop into the nucleus pulposus of the adult intervertebral disc, a soft gel-like tissue that provides cushioning and flexibility for the spine ([@bib41]).

Degeneration of the intervertebral disc leads to extensive back pain, one of the top global causes of years lived with disability ([@bib30]). Treatment primarily consists of managing the pain symptoms, or in more progressed disease includes extensive surgery. One of the major goals of the tissue-engineering field is to identify cells and tissues that will enable novel regenerative therapies to slow down and possibly reverse the degenerative process. Here, we uncover a novel cellular subpopulation in the notochord sheath that emerges at the site of damage and is maintained until formation of a repaired adult vertebra structure. Surprisingly, this subpopulation expresses *wt1b* despite no evidence of *wt1b* expression in physiological notochord development or ossification. Our findings suggest that the zebrafish notochord is protected by a novel wound-specific programme that seals the notochord wound in the embryo and contributes to the subsequent adult vertebra at the injury site.

Results {#s2}
=======

Wound-specific expression of *wt1b* in the notochord {#s2-1}
----------------------------------------------------

Given the expression of *wt1b* in the regenerating heart, we wanted to explore the expression of *wt1* in other regenerating tissues, and began with the tail fin regenerative processes. There are two *wt1* paralogues in zebrafish, *wt1a* and *wt1b*, and so we performed tail fin amputations on zebrafish larvae 3 days post fertilization (dpf) using *Tg(wt1a:gfp)* and *Tg(wt1b:gfp)* transgenic lines ([@bib5]; [@bib43]) ([Figure 1---figure supplement 1a](#fig1s1){ref-type="fig"}). Surprisingly, we discovered that tail fin amputations including partial removal of the notochord triggered a change of cellularity in the notochord, coupled with the specific, de novo upregulation of GFP in a *Tg(wt1b:gfp)* transgenic line. This response was specific to *wt1b* because we did not observe expression of GFP in the notochord of *Tg(wt1a:gfp)* tail fin amputated larvae ([Figure 1---figure supplement 1b--f](#fig1s1){ref-type="fig"}).

Next, we developed a needle-based assay to induce localized damage in the developing zebrafish notochord independent of tail fin amputation. Needle injury was induced in 3 dpf *Tg(wt1b:gfp)* that had been crossed with *casper* fish to remove pigmentation and imaged at 72 hr post injury (hpi) ([Figure 1a](#fig1){ref-type="fig"}). Needle induced wounds triggered a similar, albeit stronger *wt1b:gfp* response compared to the tail fin amputations, that was specifically localised to the site of the wound ([Figure 1b](#fig1){ref-type="fig"}). Time course imaging showed a progressive expansion of the damaged area over 72 hr, with an increasing expression of GFP signal, concomitant with a change of cellularity in the notochord ([Figure 1c](#fig1){ref-type="fig"}). Importantly, this was not observed in uninjured zebrafish controls ([Figure 1c](#fig1){ref-type="fig"}) or in notochord injured *Tg(wt1a:gfp)* transgenic larvae (data not shown). Histological staining of the damaged area revealed the presence of a subpopulation of cells at the site of injury, which contrasted morphologically with the uniform, vacuolated inner cells of the notochord ([Figure 1d](#fig1){ref-type="fig"}). These cells stained positively for GFP and for endogenous Wt1 protein by immunohistochemistry, validating the faithful expression of the transgene with endogenous *wt1b* expression in this response ([Figure 1e](#fig1){ref-type="fig"}; [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). *Tg(wt1b:gfp)* expression was not detected in the notochord outside the wound response by immunohistochemistry for GFP or for Wt1 protein ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Thus, following notochord injury, an unanticipated expression of *wt1b* marks a subpopulation of cells that emerges in the notochord and is associated with the wound.

![Notochord injury triggers local and sustained *wt1b* expression.\
(**a**) Schematic of notochord needle-injury protocol. 3 dpf *Tg(wt1b:gfp)*; casper larvae are injured above the yolk sac (YS; at somite 14 or 15) and followed for 72 hr. (**b, c**) Images of *Tg(wt1b:gfp); casper* zebrafish trunk over time following notochord needle injury, and uninjured matched controls. GFP signal is associated with a change of cellularity in the injured notochord (inset). n \> 10; experimental replicates \>10. Scale bar: 100 µm. (**d**) H and E staining of the injured area at 6 hpi and 24 hpi highlighted the progressive change in cellularity at the site of the injury (arrow). n = 5; experimental replicates = 1. Scale bar: 20 µm. (**e**) Immunohistochemistry of the injured area with α-GFP and α-Wt1 antibodies. n \> 10; experimental replicates = 5. Scale bar: 20 µm. dpf = days post fertilization; hpi = hours post injury; H and E = haematoxylin and eosin.](elife-30657-fig1){#fig1}

*wt1b* expressing cells emerge from the notochord sheath {#s2-2}
--------------------------------------------------------

To determine the origin of the wound-specific *wt1b*^+^ cells, we examined *wt1b* expression in the vacuolated cells of the notochord, and in notochord sheath cells using two different transgenic lines. The *Tg(SAGFF214A:gfp)* transgenic line labels the cytoplasm of the inner vacuolated cells, and the *Tg(R2col2a1a:mCherry)* transgenic line labels notochord sheath cells. While *col2a1a* is expressed in all notochord cells ([@bib1]), a *Tg(R2col2a1a:mCherry)* line had been generated with a 310 bp conserved regulatory element of the *col2a1a* promoter that is specifically expressed in the surrounding notochord sheath cells ([Figure 2a](#fig2){ref-type="fig"}) ([@bib8]; [@bib60]).

![*wt1b:gfp* expressing notochord sheath cells populate the site of injury in the damaged notochords.\
(**a**) Schematic diagram of the notochord and transgenic lines used in this study. The notochord is composed of an inner population of highly vacuolated cells (green arrow; *SAGFF214A:gfp*), surrounded by a layer of epithelial-like sheath cells (red arrow; *R2col2a1a:mCherry*), encapsulated by a thick layer of extracellular basement membrane (grey arrow). (**b**) Schematic of experimental design: 3dpf *Tg(wt1b:gfp; R2-col2a1a:mCherry); casper* larvae were needle-injured and imaged at 0, 24 and 72 hpi. (**c**) Needle damage led to the formation of a cell-free gap in the layer of notochord sheath cells (0 hpi -- injured; dashed line). GFP expression can be observed in the notochord sheath cells surrounding the area of damage by 24 hpi (inset: cross-sectional view) and these appear to engulf the injured area by 72 hpi (inset). n \> 10; experimental replicates \>10. Scale bar: 100 µm. (**d**) Multiphoton time-lapse imaging of wound site. Initial upregulation of GFP occurs at eight hpi in the *R2-col2a1a:mCherry* positive cells (arrow) and propagates across the injured area over the next 40 hr to form a seal in the notochord. n = 8; experimental replicates = 1. Scale bar: 100 µm. (**e**) Representative example of FACS analysis of cell populations in injured and non-injured zebrafish trunk tissue. GFP^+^mCherry^+^ double positive cells are present in injured *Tg(wt1b:gfp; col2a1a:mCherry)* at 72 hpi. Percentage of fluorescent cells are reported. Note that the dissected tissue can also encompass *wt1b:gfp* expressing cells in the posterior end of the pronephric duct (see also [Figure 1c](#fig1){ref-type="fig"}). n = 35 larvae per group; experimental replicates = 4. dpf = days post fertilization; hpi = hours post injury.](elife-30657-fig2){#fig2}

A needle-induced notochord wound in the *Tg(SAGFF214A:gfp)* transgenic line showed that GFP-expressing cells were lost rapidly upon injury, creating a gap in the row of vacuolated cells. Eventually, this gap was filled with new cells by 144 hpi ([Figure 2---figure supplement 1a,b](#fig2s1){ref-type="fig"}). The *SAGFF214A:gfp* response was distinct from the *wt1b*^+^ response in time (emerging at 72 hpi compared with 24 hpi), size and number (few and large compared with numerous and small), and in coverage of the wound (visible gaps remaining at the site compared with filling the damage site). These data suggest that *wt1b* expressing cells are distinct from the vacuolated cells at the site of injury.

Next, we explored the role of the notochord sheath cells in this process. We crossed the *Tg(wt1b:gfp)* transgenic line to the *Tg(R2col2a1a:mCherry)* transgenic line. Live confocal and multiphoton imaging revealed *wt1b:gfp* expression in the *R2col2a1a:mCherry* notochord sheath cells following needle induced notochord damage ([Figure 2b--d](#fig2){ref-type="fig"}; [Video 1](#video1){ref-type="video"}; [Figure 2---figure supplement 1c](#fig2s1){ref-type="fig"}), and this was supported by imaging of histological sections ([Figure 2---figure supplement 1d](#fig2s1){ref-type="fig"}). *wt1b:gfp* co-expression with *R2col2a1a:mCherry* was visible by 24 hpi in a ring surrounding the notochord vacuolated cells, and by 72 hpi the *wt1b:gfp* subpopulation of sheath cells had migrated into central aspects of the notochord to fill the wound and produce a visible stopper-like seal that was contiguous with the notochord sheath cells, and filled the gap in the notochord caused by the wound ([Figures 1e](#fig1){ref-type="fig"} and [2d](#fig2){ref-type="fig"}).

###### 

Time-lapse imaging of two-photon microscopy of *Tg (wt1b:gfp; R2col2a1a:mCherry)* zebrafish larvae following needle injury over 48 hr. *wt1b:gfp* expression is upregulated in *R2col2a1a:mCherry* expressing notochord sheath cells upon needle injury, leading to the formation of a stopper like structure across the wound

10.7554/eLife.30657.009

To validate the co-expression of *wt1b:gfp* and *col2a1a:mCherry* in the wounded fish, we FACS sorted cell populations in the injured versus uninjured larvae isolated from the trunk region ([Figure 2e](#fig2){ref-type="fig"}; 35 larvae pooled per set). Both injured and non-injured larvae contained cells that expressed either GFP^+^ only (presumably *wt1b:gfp* cells of the pronephric duct that were included in the dissected tissue) or mCherry^+^ alone, but the wounded fish had significantly increased numbers of cells that co-expressed *wt1b:gfp* and *col2a1a:mCherry* (GFP^+^mCherry^+^) ([Figure 2---figure supplement 1e](#fig2s1){ref-type="fig"}).

Our evidence indicates that the notochord wound triggers a unique *wt1b*^+^ subpopulation to emerge in the notochord sheath cells. This *wt1b*^+^ sheath cell subpopulation migrates into the wound and generates a stopper-like structure, possibly to prevent further loss of notochord turgor pressure and maintain notochord integrity.

Nystatin mediated disruption of vacuolated cells leads to an increase in *wt1b:gfp* expression {#s2-3}
----------------------------------------------------------------------------------------------

We tested if the *wt1b*-response was specific to wounds that involved rupture of the sheath, or if *wt1b* expressing cells could be induced upon loss of vacuolated cell integrity alone. Mutations in *caveolin* genes lead to collapse of the vacuolated cells, with invasion and replacement from the notochord sheath ([@bib17]). We treated two-day old *Tg(wt1b:gfp; R2col2a1a:mCherry)* zebrafish with nystatin, a small molecule that binds sterols. Nystatin treatment lead to an increase in cellularity of the vacuolated notochord, similar to the phenotype seen in the notochord of *caveolin* mutants ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). GFP was expressed in a subpopulation of the mCherry-positive sheath cells at the site of cellularity. Thus, expression of *wt1b* in the sheath does not require a physical breach of the sheath, and *wt1b* expression may be applicable to a wider range of tissue stress and damage situations.

Notochord wound cells express cartilage and mesenchyme genes {#s2-4}
------------------------------------------------------------

To address the molecular process at the site of the wound, we compared the transcriptome of the trunk region in the injured and uninjured 72 hpi larvae ([Figure 3a,b](#fig3){ref-type="fig"}; n = 50 larvae per subset). Microarray analysis revealed a highly significant 131-fold increase in expression of *matrix gla protein* (*mgp*), a gene that is known to express in chondrocytic zebrafish tissues ([@bib18]) and to be involved in the inhibition of hydroxyapatite production during ectopic bone formation ([@bib49]; [@bib53]; [@bib61]) ([Figure 3c,d](#fig3){ref-type="fig"}). Other genes included mesenchymal and cell adhesion markers, such as *fn1b*, coagulation factors, such as *f13a1b,* and immune response genes, such as *zgc:92041* and *complement c6* ([Figure 3d](#fig3){ref-type="fig"}).

![Cartilage genes are expressed in the notochord-injured zebrafish.\
(**a**) Experimental plan: 3 dpf *Tg(wt1b:gfp)* larvae were needle injured and grown for 72 hr with uninjured age-matched controls (n = 50 larvae per group). (**b**) The area around the *wt1b:gfp* expression was excised at 72 hpi (dotted area) and RNA was extracted and amplified. A similar area was taken from age-matched uninjured controls. (**c**) Volcano plot displaying the differentially expressed genes between injured and non-injured larvae. The y-axis measures the mean expression value of log 10 (p-value) and separates upregulated from downregulated genes. The x-axis represents the log2 fold change of expression. Significantly upregulated genes are shown as green circles or dots and downregulated genes are shown as red circles or dots. Green dotted line represents the p-value threshold (p\<0.05) and blue dotted line represents the false discovery rate (FDR) or q-value threshold (q \< 0.05). Genes with highest expression change are shown in magnified view. (**d**) Table showing the most significantly differentially expressed genes in injured larvae (q \< 0.05). Upregulated genes are shown in green and downregulated genes are shown in red. (**e**) Table showing cartilage-associated genes that were significantly upregulated in the injured larvae (p\<0.05). (**f, g**) Results of quantitative real-time PCR (qRT-PCR) of *mgp* and *sox9b.* The y-axis indicates the difference between the cycle threshold (Ct) value of the gene of interest and the Ct value of *β-actin* for *mgp* and *gapdh* for *sox9b*. Note that the y-axis is inverted to ease interpretation. Bars represent standard deviation from the mean. *mgp* \*\*p=0.025; *sox9b* \*\*\*p=0.007; paired t-test; Experimental replicates: *mgp* = 2; *sox9b* = 1 at 48 hpi, and 1 at 72 hpi (40 embryos pooled per replicate). See Source Data files ([Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}; [Figure 3---source data 2](#fig3sdata2){ref-type="supplementary-material"}).\
10.7554/eLife.30657.011Figure 3---source data 1.Raw data and statistical analyses for [Figure 3f](#fig3){ref-type="fig"}.Results of quantitative real-time PCR (qRT-PCR). The cycle threshold (Ct) value of the gene of interest(mpg) and the Ct value ofβ-actinare indicated for each sample. Subsequent calculations are also included. Paired t-test;\*\* p= 0.025. Experimental replicates=2; (40 embryos pooled per replicate).\
10.7554/eLife.30657.012Figure 3---source data 2.Raw data and statistical analyses for [Figure 3g](#fig3){ref-type="fig"}.Results of quantitative real-time PCR (qRT-PCR). The cycle threshold (Ct) value of the gene of interest(sox9b) and the Ct value ofgapdhare indicated for each sample. Subsequent calculations are also included. Paired t-test;\*\*\* p= 0.007 Experimental replicates =1 at 48 hpi, and 1 at 72 hpi (40 embryos pooled per replicate).](elife-30657-fig3){#fig3}

The increased expression of *mgp* and *f13a1b* genes implicated the de novo acquisition of chondrogenic features in the injured tissues. Chondrogenic cells in the endochondral tissues of the craniofacial, fin bud and axial skeletons express *mgp* ([@bib18]) and *FXIIIA* expression is localized to the developing chondrogenic mesenchyme of the pectoral fin bud ([@bib9]). The expression of cartilage genes was unexpected because ossification around the zebrafish notochord occurs via the formation the chordacentra, and does not require the establishment of cartilage anlagen ([@bib4]; [@bib15]. To examine the expression of other chondrogenic genes, we analyzed the top 100 significant genes and found an increase in expression of *sox9b*, the master regulator of chondrogenesis, five collagen genes associated with chondrogenic tissues (*col2a1a*, *col2a1b*, *col11a2*, *col9a1* and *col9a2*), the cartilage-specific extracellular structural protein Aggrecan, a microRNA regulator of chondrogenesis microRNA140 and the matrix-cell anchor protein chondroadherin (*chad*) ([Figure 3e](#fig3){ref-type="fig"}). To validate these findings at the molecular level, we isolated sections of damaged and undamaged tissue, and performed qRT-PCR for *matrix gla protein* (*mgp)* and *sox9b*. We chose these two genes because *mgp* was highly expressed in the microarray analysis and important for bone organization, and because Sox9 is a master cartilage transcription factor. We found *mgp* and *sox9b* to be highly upregulated in the injured tissue compared with the uninjured tissue ([Figure 3f,g](#fig3){ref-type="fig"}). Our results reveal that notochord wounding leads to the formation of a *wt1b*-positive sheath subpopulation that is characterised by an unexpected increase in genes associated with cartilage.

Single-cell and 10 cell sequencing of *wt1b*-expressing sheath cells {#s2-5}
--------------------------------------------------------------------

To address the molecular nature of the GFP^+^mCherry^+^ expressing cells, we performed RNA sequencing of single-cells and 10 cell pools of FACS sorted GFP^+^ cells, mCherry^+^ cells and GFP^+^mCherry^+^ cells from injured zebrafish (3dpi) using the SMARTseq2 protocol ([Supplementary file 1](#supp1){ref-type="supplementary-material"}; [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) ([@bib27]; [@bib44]). To avoid batch effects, all experimental conditions were sorted onto the same 96 well plate and processed simultaneously ([@bib3]). Sequencing reads were processed using the Scater pipeline ([@bib37]). Unbiased Single cell consensus clustering (SC3) of the whole transcriptomes revealed that the GFP^+^ cells, mCherry^+^ cells and GFP^+^mCherry^+^ cells clustered into three distinct subpopulations (SC3 cluster 1: GFP^+^, 2: GFP^+^mCherry^+^ and 3: mCherry^+^) ([Figure 4a--c](#fig4){ref-type="fig"}) ([@bib28]). Single and 10 cell populations clustering together suggested that sorting conditions led to homogenous 10 cell populations. Expression of *wt1b* was detected in SC3 clusters 1 and 2, and *col2a1a* was expressed in SC3 clusters 2 and 3 ([Figure 4b](#fig4){ref-type="fig"}). *wt1a* transcripts were not detected in any of the SC3 clusters. Together with the Wt1b antibody immunohistochemistry ([Figure 1e](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}), detection of *wt1b* transcripts in GFP^+^mCherry^+^ cells prove endogenous *wt1b* expression in the notochord damage response.

![Single-cell and 10 cell sequencing of *wt1b*-shealth cell populations.\
(**a**) Single-cell and 10 cell SC3 unbiased clustering analysis reveals three distinct cell populations marked by *GFP* (cluster 1), *mCherry* (cluster 3), or *GFP* and *mCherry* (cluster 2). (**b**) *GFP*, *mCherry*, *wt1b* and *col2a1a* expression in 10 cell clusters. (**c**) Top 10 differential gene expression marker genes for 10 cell clusters. (**d**) Expression of *mgp* in different cell populations of injured zebrafish notochords. RNA was isolated from FACS sorted GFP, RFP and GFP/RFP expressing cells of the notochord of *Tg(wt1b:gfp; R2-cola2a1a:mCherry)* embryos, and gene expression was determined by qPCR. The y-axis indicates the difference between the cycle threshold (Ct) value of the gene of interest and the Ct value of beta-actin in injured and uninjured notochord. The y-axis is inverted for ease of interpretation. p-values are determined by paired t-test. Bars represent standard deviation. *mgp*: \*\*p=0.035. Experimental replicates = 2. See Source Data file ([Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"}). (**e**) Bar chart depicting functional analysis of differentially expressed genes between 10 cell SC3 cluster 2 and cluster three against five databases. Normalised enrichment score (NES, x-axis) calculated using online functional enrichment tool WebGestalt resource. Coloured bars match specific databases. (**f**) Images of the wound site seven days post injury in *Tg(wt1b:gfp;col2a1a:mCherry); nacre^-/-^* embryos. Arrows indicate vacuole-like structures. n = 7; experimental replicates: 1. Scale bar: 50 μm. (**g**) Gene set enrichment analysis (GSEA) of cartilage genes in *wt1*-expressing sheath cell (cluster 2) 10 cell group clusters (21 out of 82 genes were positively enriched; NES = 0.90). (**h**) GSEA of WT1 gene targets in *wt1b*-expressing sheath cell (cluster 2) 10 cell group clusters (19 out of 56 target genes were negatively enriched; NES = −1.44). (**i**) Heatmap of expression of WT1-interacting partners in 10 cell cluster 2 and cluster 3. (**j**) *p53* RNA expression in 10 cell clusters. (**k**) GSEA of p53 targets genes in *wt1b*-expressing sheath cell (cluster 2) 10 cell group clusters (358 out of 1442 genes were positively enriched; NES = 1.17). (**l**) GSEA of common p53 and WT1 gene targets in *wt1b*-expressing sheath cell (cluster 2) 10 cell group clusters (10 out of 19 genes were negatively enriched, NES = −1.11).\
10.7554/eLife.30657.015Figure 4---source data 1.Raw data and statistical analyses for [Figure 4d](#fig4){ref-type="fig"}.Results of quantitative real-time PCR (qRT-PCR). RNA was isolated from FACS sorted GFP, RFP and GFP/RFP expressing cells of the notochord ofTg(wt1b:gfp; R2-cola2a1a:mCherry)embryos, and gene expression was determined by qPCR. The cycle threshold (Ct) value for the gene of interest(mpg) and the Ct value ofβ-actinare indicated. Subsequent calculations are also indicated . Paired t-test; \*\*\* p=0.001; \*\* p=0.035. Experimental replicates=2. Only one replicate has been used to generate the graph.](elife-30657-fig4){#fig4}

To avoid confounding factors, for example different ratios of single to 10 cell trancriptomes, when calculating differential expression, we used SC3 on the 10 cell populations only. We found consistent clustering of the different cell populations (GFP^+^, GFP^+^mCherry^+^ and mCherry^+^). Notably, differential marker gene expression in GFP^+^mCherry^+^ cells included the *mgp*, *fn1b* and *f13a1b* genes ([Figure 4c](#fig4){ref-type="fig"}) that were highly upregulated in the wounded tissue ([Figure 3d](#fig3){ref-type="fig"}). To validate our findings, we isolated injured notochord tissue from 3dpi and FACS sorted GFP^+^, mCherry^+^ and GFP^+^mCherry^+^ double positive cells, and performed qRT-PCR on sorted cell populations for *mgp,* a SC3 cluster 2 cell marker gene. Expression of *mgp* was selectively enriched in GFP^+^mCherry^+^ double positive cells ([Figure 4d](#fig4){ref-type="fig"}).

We next calculated differentially expressed genes between GFP^+^mCherry^+^ cells compared with the mCherry^+^ cells using SCDE ([@bib25]). Based on the SCDE output genes were ranked and the ranked list was used with the WEB-based gene set analysis toolkit (WebGestalt) to explore the functional nature of the GFP^+^mCherry^+^ cells compared with the mCherry^+^ cells ([Figure 4e](#fig4){ref-type="fig"}). Expression of genes in signaling pathways, such as the TGF-ß pathway were reduced, while vacuolar and lysosomal pathway components were highly enriched in the GFP^+^mCherry^+^ cells comparing gene sets from multiple databases. To explore the possibility of lysosome activity in more detail, we performed confocal imaging analysis of the wound site at 7 dpi and observed some GFP^+^mCherry^+^ cells with large inclusions (presumably vacuoles), in the cytoplasm ([Figure 4f](#fig4){ref-type="fig"}). This suggests that some GFP^+^mCherry^+^ cells may become vacuolated to replace those lost upon injury.

Next, given the expression of cartilage genes by microarray analysis, we performed gene set enrichment analysis (GSEA) with a list of zebrafish cartilage genes curated in AmiGO ([Supplementary file 1b, 1c](#supp1){ref-type="supplementary-material"}). Cartilage genes were significantly enriched in the cell cluster 2 (GFP^+^mCherry^+^ cells) compared with cell cluster 3 (mCherry^+^ cells), suggesting that it is specifically the *wt1b*-expressing sheath cells that express genes involved in cartilage formation ([Figure 4g](#fig4){ref-type="fig"}).

To explore the role of WT1 in the wound response, we compiled a list of WT1 target genes, and compared it with the rank order list of RNA transcripts expressed in the GFP^+^mCherry^+^ cells by gene set enrichment analysis (GSEA) ([Supplementary file 1b, 1d](#supp1){ref-type="supplementary-material"}) ([@bib52]). Unexpectedly, we discovered a set of WT1 regulated genes that were specifically repressed in the GFP^+^mCherry^+^ cells ([Figure 4h](#fig4){ref-type="fig"}). WT1 can function with co-factors to repress or activate gene expression, and this new signature suggests that Wt1b may function as a repressor in the notochord damage response. Next, we performed gene expression analysis for all WT1 co-transcription factors described in ([@bib54]), and found *p53* to be most differentially expressed in GFP^+^mCherry^+^ cells compared with mCherry^+^ cells ([Figure 4i,j](#fig4){ref-type="fig"}). GSEA analysis showed that p53 target genes are enriched overall in the GFP^+^mCherry^+^ cell populations ([Figure 4k](#fig4){ref-type="fig"}; [Supplementary file 1b, 1e](#supp1){ref-type="supplementary-material"}), however, when we specifically analysed the gene expression for those genes that were present in both the WT1 and p53 target gene list ([Supplementary file 1f](#supp1){ref-type="supplementary-material"}), we found a strong repression of genes that are regulated by both WT1 and p53 ([Figure 4l](#fig4){ref-type="fig"}). These data uncover an unexpected co-operation between Wt1b and p53 to negatively regulate a select subset of genes in the *wt1b*-expressing sheath cell subpopulation during the wound response.

Vertebra form at the repair site via an unusual cartilage intermediate {#s2-6}
----------------------------------------------------------------------

The expression of cartilage genes in the wound tissue and in the *wt1b*-expressing sheath cell subpopulation suggests that the notochord wound may induce a previously unknown and alternative bone development process. We stained injured and control animals with alcian blue and alizarin red, which highlight cartilage and bone respectively. Cartilage was clearly visible at the site of injury as soon as three dpi ([Figure 5a](#fig5){ref-type="fig"}). This staining was significantly stronger and distinct from the highly coordinated segmental cartilage staining that normally occurs during larval development in the region of the future intervertebral discs, which is clearly visible in both injured and non-injured controls by 14 dpi ([Figure 5a](#fig5){ref-type="fig"}). Similarly, the alizarin red dye identified the anterior to posterior forming chordacentra rings during larval development. However, in injured zebrafish larvae, the normally uniform mineralization pattern was interrupted around the site of damage, leading to delayed formation of the chordacentra at later stages ([Figure 5a](#fig5){ref-type="fig"}). By 18 dpi, the injured site began to express bone matrix, and was visibly flanked by cartilage expressing segments ([Figure 5b](#fig5){ref-type="fig"}). This is unusual because during norm-physiological development of the vertebral elements, cartilage and bone stains mark distinct regions of the notochord.

![De novo bone formation occurs via a cartilage intermediate at the site of injury.\
(**a**) Alcian blue and Alizarin red staining at the site of injury in 3 and 14 dpi larvae. Ectopic cartilage deposit is indicated by arrow. n \> 10; experimental replicates = 8. Scale bar left panels: 400 µm; scale bar right panels (zoomed images): 200 µm. (**b**) Alcian blue and Alizarin red staining at the site of injury at 18 dpi indicates the presence of bone and cartilage at the repair site (blue arrow = cartilage; red arrow = bone). n = 2; experimental replicates = 8. Scale bar: 200 µm. (**c**) Alcian blue and alizarin red staining of 30 dpi larvae reveals the formation of a smaller vertebra in the damaged area. n \> 10; experimental replicates = 3. Scale bar left panels: 400 μm; scale bar right panels (zoomed images): 200 μm. (**d**) Live imaging of calcein stained zebrafish at 21 and 38 dpi in injured and uninjured fish. Vertebrae at damage site are indicated by yellow asterisks. Black asterisk denotes intestinal fluorescence. n = 5; experimental replicates = 1. Scale bar 21 hpf: 200 µm; scale bar 21 hpf zoomed: 100 µm; scale bar 38 hpf: 200 µm; scale bar 38 hpf zoomed: 100 µm. (**e**) The relative vertebra size difference (Δ size) between vertebrae at the site of injury (injured) and vertebrae in non-injured areas (uninjured). Vertebrae at the site of injury were significantly smaller than uninjured vertebrae (Unpaired t-test; \*\*\*p\<0.0001 two-tailed; mean ±SEM uninjured larvae = 0.9506 + /- 0.02102 n = 7; mean ±SEM injured larvae = 0.7432 + /- 0.0284 n = 7; measurements taken at 30 and 38 dpi).](elife-30657-fig5){#fig5}

To evaluate the outcome of the injury in the ossification process, wild-type larvae were injured and stained using live calcein dye at 21 and 38 dpi ([@bib11]). The vertebrae that eventually formed were often smaller in a given space interval and appeared supernumerary compared with uninjured age-matched controls ([Figure 5c--e](#fig5){ref-type="fig"}).

The notochord patterns spine formation via the activation of various signals, and has been proposed to be an essential component of chordacentra formation ([@bib4]; [@bib15]). Entpd5a (ectonucleoside triphosphate diphosphohydrolase 5) is an E-type NTPase that is expressed in osteoblasts and is essential for skeletal morphogenesis ([@bib21]). Recent evidence shows that metameric expression of *entpd5a* in notochord sheath cells is an essential requirement for the patterned formation of chordacentra rings (*LL-F and SS-M, personal communication*), with *entpd5a* expression serving as a readout for mineralizing activity ([@bib21]). We crossed the *Tg(wt1b:gfp)* transgenic line to a *Tg(entdp5a:pkRed)* line and followed the wound response. *wt1b* and *entpd5a* expressing cell populations were closely associated at the wound site indicating that mineralizing *entpd5a* cells may directly contribute to *wt1b*^+^ associated chordacentra response ([Figure 6a,b](#fig6){ref-type="fig"}).

![Distinct and closely associated *wt1b* and *entpd5a* subpopulations emerge at the damage site.\
(**a**) Live-imaging at the site of notochord injury in *Tg(wt1b:gfp; entpd5a:dkRed)* larvae. Expression of *wt1b:gfp* and *entpd5a:pkRed* at site of damage (green arrows and red arrows respectively) in injured and uninjured fish. n \> 10; experimental replicates = 5. Scale bar: 50 µm. (**b**) Cryo-section of the injured area confirms distinct *wt1b:gfp* and *entpd5a:dkRed* subpopulations at site of damage. n \> 10; experimental replicates = 2. Scale bar: 20 µm.](elife-30657-fig6){#fig6}

Next, we wanted to explore the relationship between *entpd5a* expression domains and the vertebrae formation at the wound site. By 5 dpf, metameric *entpd5a* expression domains are clearly visible in the anterior notochord. We wounded the notochord in 5 dpf and 7dpf fish either in between two adjacent *entpd5a*-expression domains or aimed at the center of an *entpd5a*-expression domain. Fish that had been wounded between the *entpd5a*-expression domains appeared to have normal vertebrae structures at 25 dpi (n = 6/6). In contrast, damaging the *entpd5a*-expression domain led to a supernumerary vertebra at the wound site (n = 4/4; [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}).

Taken together, these results indicate that wounding alone is not sufficient to alter the vertebrae number, and that *entpd5a* expression domains likely play a role in vertebrae formation following injury. These experiments raise the possibility that the notochord wound assay at 3 dpf disrupts an as of yet unknown precursor cell population. Up-regulation of *entpd5a* at the damage site may be part of a patho-physiological wound repair response that disrupts and/or engages with a precursor cell population (such as the metameric *entpd5a* expression) leading to altered vertebra(e) in the adult.

*wt1b*^+^ expression perdures into the adult vertebrae {#s2-7}
------------------------------------------------------

We noticed that the *Tg(wt1b:gfp)* transgene expression was always associated with the site of vertebrae formation in the injured zebrafish that were raised to adulthood. To determine if *wt1b* expression was transient at the wound, or sustained throughout the repair process, we raised needle injured *Tg(wt1b:gfp); casper* zebrafish larvae for up to 38 days.

GFP expression was sustained at the wound site, remaining in a small, cellular population at the site of damage, even as chordacentra developed and mineralized around the notochord over time ([Figure 7](#fig7){ref-type="fig"}). Small GFP expressing cells were further confirmed by α-GFP staining at the site of damage ([Figure 7b](#fig7){ref-type="fig"}). Strikingly, the *Tg(wt1b:gfp)* transgene maintained expression at this site up to 38 dpi ([Figure 7c,d,g](#fig7){ref-type="fig"}).

![*wt1b* expressing cells are closely associated with vertebral development after injury.\
(**a**) Images of *Tg(wt1b:gfp*) zebrafish following needle injury at 3 dpf and raised to 28 dpi. n \> 10; experimental replicates = 4. Scale bar left panels: 100 µm; scale bar right panels: 200 µm. (**b**) α-GFP staining of 28 dpi larvae at the site of the healing notochord wound and in the kidney. n = 5; experimental replicates = 1. Scale bar left panels: 50 µm. (**c**) Image of fish from [Figure 5a,c](#fig5){ref-type="fig"}, stained with alizarin red and imaged for *wt1b:gfp* expressing cells. GFP positive cells are found within the ectopic vertebra (white arrow and inset). n = 4; experimental replicates = 1. Scale bar left panels: 100 μm. (**d**) Long-term follow up of alizarin red stained *Tg(wt1b:gfp); casper* larvae shows that chordacentra formation is delayed around the site of injury. GFP cells mark the site of the future vertebra. n = 6; experimental replicates = 2. Scale bar: 100 µm; scale bar zoomed images: 50 µm. (**e**) Confocal imaging of 15, 21 and 28 dpi larvae reveals an overlapping expression between the *wt1b:gfp* expressing cells and the forming chordacentra (alizarin red stained) in the injured *Tg(wt1b:gfp); casper* larvae. n \> 10; experimental replicates = 3. Scale bar: 100 µm. Imaging views are lateral, angled and cross-section view. (**f**) Confocal imaging highlights the overlapping presence of bone (alizarin red stained) and *wt1b:gfp* cells at the wound in 18 dpi larvae (arrow). n \> 10; experimental replicates = 3. Scale bar: 100 µm. (**g**) Confocal scans of 24 dpi *Tg(wt1b:gfp)* larvae stained with alizarin red and expressing GFP at the injury site following notochord injury compared with uninjured control fish. GFP positive cells are present within the vertebrae at the injury site (arrow). Scale bar left fish: 1000 µm; scale bar on vertebrae images: 100 µm.](elife-30657-fig7){#fig7}

To gain a better understanding of how *wt1b:gfp* expressing cells engage with the newly forming vertebrae, we carried out live, confocal imaging of the area of damage ([Figure 7e--g](#fig7){ref-type="fig"}). The analysis revealed the presence of both fused and unfused vertebrae at the damaged site, and the sustained and strong expression of *wt1b:gfp* expressing cells associated with the developing vertebra at the repair site area ([Figure 7f](#fig7){ref-type="fig"}), even in fully formed spine structures ([Figure 7g](#fig7){ref-type="fig"}).

Taken together these results indicate that *wt1b:gfp* expressing cells both mark a subpopulation of cells that are rapidly activated at the site of the wound and also that these cells persist until adulthood, possibly orchestrating local vertebrae formation with wound repair.

Discussion {#s3}
==========

We have uncovered wound-specific cellular heterogeneity in the zebrafish notochord that perdures throughout the wound healing process and during adult vertebra formation at the injury site ([Figure 8](#fig8){ref-type="fig"}). We discover that wounding leads to localized *wt1b* expression in the notochord sheath cells which then invade the site of the injury to form a stopper-like structure, likely to maintain notochord integrity. We show the specific de novo expression of *wt1b* in notochord sheath cells following wounding, despite an absence of *wt1b* expression during notochord development ([Figure 1e](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}).

![Schematic of the notochord wound response.](elife-30657-fig8){#fig8}

Very recently, Bagnat and colleagues reported the identification of notochord sheath cells involved in the replacement of vacuolated cells lost due to motion-dependent mechanical damage to the notochord in caveolin mutants ([@bib17]). In this context, sheath cells invade the vacuolated cell layer and differentiate into vacuolated cells to maintain turgor pressure. While we observe that most *wt1b*-expressing cells are tightly associated with a stopper-like (scar-like) structure from embryo to adult ([Figure 7](#fig7){ref-type="fig"}), we find some *wt1b* expressing cells appear vacuolated at the injury site at later stages (7 days post injury; [Figure 4f](#fig4){ref-type="fig"}), and that *wt1b*-expressing cells express vacuolar genes ([Figure 4e](#fig4){ref-type="fig"}). We also detected *entpd5a* expressing cell subpopulations at the wound that are distinct from *wt1b* expressing cells ([Figure 6](#fig6){ref-type="fig"}). These studies highlight a previously unknown complex and heterogeneous nature of the sheath cell populations, and suggest that the notochord sheath can sense and respond to different types of damage. Motion-dependent shear stress in *caveolin* mutants causes loss of vacuolated cells that are replaced by new vacuolated cells that arise from the sheath ([@bib17]), while acute damage (i.e. needle injury) that encompasses sheath and vacuolated cell damage, leads to sheath cells forming a seal that marks the site of new cartilage and vertebra ([Figure 8](#fig8){ref-type="fig"}). We show that *wt1b* expression marks a subpopulation of sheath cells in both damage responses ([Figure 1](#fig1){ref-type="fig"}, [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), and suggest that additional factors are involved in the ultimate fate of *wt1b*-expressing cells (i.e. vacuolated cells versus scar like structure).

To address the function of Wt1b in the wound response, we generated a CRISPR-Cas9 genetic mutant that removes part of the C-terminal zinc-finger domains that are essential for WT1 function in mammalian systems. We find homozygous *wt1b* mutant zebrafish show no overt difference from wild type fish in the wound response ([Figure 8](#fig8){ref-type="fig"}; [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). However, given the dramatic up-regulation of *wt1b* upon wounding, and given the continued expression up to adult stages, we consider it unlikely that Wt1b has no role in the process. Compensatory mechanisms have to be considered, and indeed, we find a small, but significant increase in *wt1a* in *wt1b^∆5/∆5^* wounded tissue. Furthermore, compensatory mechanisms downstream the Wt1b-p53 axis could mask a role, and further analysis beyond the scope of this study will be required to fully understand the functional significance of Wt1b in this subpopulation of cells.

By leveraging gene expression profiling, and single-cell and 10 cell sequencing of the wounded tissue, we discovered a mechanism for vertebra formation via a cartilage intermediate at the injury site. This is completely unexpected as in zebrafish, ossification of the chordacentra does not require the establishment of a cartige anlagen, but form via the direct mineralization of the fibrous notochord sheath ([@bib4]; [@bib16]). The activation of *wt1b* in sheath cells that migrate towards the center of the notochord is reminiscent of the situation where *wt1b* expression is reactivated in epicardial cells that undergo EMT to produce vascular progenitors and migrate into the heart ([@bib36]). This raises the question whether notochord sheath cells may also be mesothelial in nature and if the invading *wt1b* expressing cells are produced via an EMT or, perhaps more accurately, a mesothelial to mesenchyme transition. While *wt1b*-positive cells express some mesenchymal genes ([Figure 3d](#fig3){ref-type="fig"}), we did not find evidence that these cells express classical gene signatures related to known EMT processes in the damaged tissue. This may be evidence of an as of yet unknown process in the wound response, or possibly because the EMT process was primarily completed by the time of our analysis at 3 days post injury.

Surprisingly, we have uncovered a new Wt1b-p53 gene expression signature that is specifically repressed in *wt1b*^+^ sheath cells ([Figure 4k](#fig4){ref-type="fig"}). p53 is a transcription factor that in addition to its well-established role as a tumor suppressor, functions to inhibit premature osteoblast differentiation and bone remodeling ([@bib32]). Several lines of evidence support a direct WT1-p53 interaction, and that p53 can modify activity of WT1 transcriptional activity from an activator to a repressor on select promoters in vitro ([@bib33]; [@bib34]). However, the in vivo function for the WT1-p53 interaction is not yet understood, and loss of *p53* in *wt1*-null mutant mice does not alter the *wt1-*null phenotype ([@bib38]). Here, we identify a Wt1b-p53 axis specifically in the repair of a notochord wound. The Wt1b-p53 gene signature includes repression of genes that regulate osteogenesis in mammals, including *myc* (*a* and *b*), *egr1* and *igfrb* ([@bib46]; [@bib47]; [@bib57]). We propose that repair-specific transcription factors participate in notochord healing by co-ordinating expression of cartilage genes such as *sox9* and *mgp* ([@bib49]; [@bib53]; [@bib61]), with a Wt1b-p53 transcriptional axis repressing premature expression of osteogenesis genes in the first few days following wounding. We see *entpd5*^+^ notochord sheath cells in the wound area ([Figure 6](#fig6){ref-type="fig"}), and since *entpd5* is essential for mineralization, it seems likely that these cells, in conjunction with cartilage formation at the site of injury, play a role in centrum formation ([Figure 8](#fig8){ref-type="fig"}). Eventually, smaller vertebra form at the wound site, and *wt1b:gfp* cells remain tightly associated with this/these vertebra(e) into adulthood. This mode of notochord wound healing and vertebra formation may be a salvage structure to effectively maintain structural integrity of the developing axial skeleton.

Materials and methods {#s4}
=====================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                       Designation                                             Source or reference                                                        Identifiers                                                                                                                              Additional information
  or resource                                                                                                                                                                                                                                                                                                     
  ----------------------------------- ------------------------------------------------------- -------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene (Danio Rerio)                  *sagff214a*                                             NA                                                                         ZFIN ID: ZDB-ALT-110315--2                                                                                                               

  Gene (Danio Rerio)                  *wt1a*                                                  NA                                                                         ZFIN ID: ZDB-GENE-980526--558                                                                                                            

  Gene (Danio Rerio)                  *col2a1a*                                               NA                                                                         ZFIN ID: ZDB-GENE-980526--192                                                                                                            

  Gene (Danio Rerio)                  *entpd5a*                                               NA                                                                         ZFIN ID: ZDB-GENE-100419--1                                                                                                              

  Gene (Danio Rerio)                  *sox9b*                                                 NA                                                                         ZFIN ID: ZDB-GENE-001103--2                                                                                                              

  Gene (Danio Rerio)                  *wt1b*                                                  NA                                                                         ZFIN ID: ZDB-GENE-050420--319                                                                                                            

  Genetic reagent (Danio Rerio)       Tg(entpd5:kaede)                                        [@bib19]doi: 10.1242/dev.105817                                            ZFIN ID: ZDB-ALT-150223--1: hu6867                                                                                                       Same BAC used as [@bib21] (DOI: 10.1073/pnas.1214231110) with kaede insertion at first translated ATG

  Genetic reagent (Danio Rerio)       Tg(entpd5:pkRed)                                        This paper                                                                 ZFIN ID: hu7478                                                                                                                          Same BAC used as [@bib21] (DOI: 10.1073/pnas.1214231110) with pkRed insertion at first translated ATG

  Genetic reagent (Danio Rerio)       Tg(SAGFF214a;UAS:gfp)                                   [@bib60] DOI: 10.1242/dev.051011                                           ZFIN ID: ZDB-FISH-150901--18089                                                                                                          

  Genetic reagent (Danio Rerio)       Tg(wt1b:GFP,R2col2a1a:mCherry)                          This paper                                                                 ZFIN ID: ZDB-ALT-180105--1; zfin.org:ue401Tg                                                                                             

  Genetic reagent (Danio Rerio)       Tg(wt1a:GFP)                                            [@bib5] DOI: 10.1242/dev.031773                                            ZFIN ID: ZDB-FISH-150901--2540                                                                                                           

  Genetic reagent (Danio Rerio)       Tg(wt1b:GFP)                                            [@bib43] DOI: 10.1016/j.ydbio.2007.06.022                                  ZFIN ID: ZDB-FISH-150901--1774                                                                                                           

  Genetic reagent (Danio Rerio)       casper                                                  [@bib58] DOI: 10.1016/j.stem.2007.11.002                                   ZFIN ID: ZDB-ALT-990423--22                                                                                                              

  Genetic reagent (Danio Rerio)       zebrafish codon optimised cas9 mRNA                     [@bib23] DOI: 10.1073/pnas.1308335110                                                                                                                                                                               

  Genetic reagent (Danio Rerio)       Wt1b p.F319fsX321                                       this paper                                                                 ZFIN ID: ZDB-ALT-180105--2; zfin.org:ue402                                                                                               zebrafish wt1b mutant line, mutation is in the exon coding the zinc finger 2

  Genetic reagent                     Tol2 transposase                                        [@bib24] DOI: 10.1186/gb-2007--8 s1-s7                                                                                                                                                                              

  Antibody                            anti-WT1 (rabbit polyclonal)                            This paper, Cambridge Research Biochemicals antibody production services                                                                                                                                            (1:25000); anti-WT1 was designed using the TARGET antibody production protocol from Cambridge Research Biochemicals using a conserved protein sequence from the C-terminal of the zebrafish Wt1a and Wt1b proteins.

  Antibody                            AlexaFluor 488 antibody (rabbit polyclonal)             Invitrogen                                                                 Donkey anti-Rabbit IgG (H + L) Secondary Antibody, Alexa Fluor 488: R37602; RRID:[AB_221544](https://scicrunch.org/resolver/AB_221544)   (1:800)

  Antibody                            anti-GFP (rabbit polyclonal)                            Cell Signaling Technology                                                  Cell Signaling Technology:GFP Antibody (Rabbit): 2555S; RRID:[AB_10692764](https://scicrunch.org/resolver/AB_10692764)                   (1:1500)

  Recombinant DNA reagent (plasmid)   R2-col2a1a:mCherry                                      [@bib8] DOI: 10.1016/j.ydbio.2011.06.020                                                                                                                                                                            

  Sequence-based reagent              wt1b mutant sgRNA                                       this paper                                                                                                                                                                                                          GGTCAGACCTGGAGAAGCGG

  Commercial assay or kit             Dako REAL EnVision\                                     Dako                                                                       Dako REAL EnVision Detection System, Peroxidase/DAB+,\                                                                                   
                                      Detection System kit                                                                                                               Rabbit/Mouse: Code K5007                                                                                                                 

  Commercial assay or kit             Low Input Quick Amp Labelling Kit                       Agilent Technologies                                                       Low Input Quick Amp Labeling Kit, one-color:5190--2305                                                                                   

  Commercial assay or kit             Nextera XT DNA Library Preparation Kit (96 samples),    Illumina                                                                   Nextera XT DNA Library Preparation Kit (96 samples),: Cat: FC-131--1096                                                                  

  Commercial assay or kit             4 × 44K Whole Zebrafish (V3) Genome Oligo Microarray    Agilent Technologies                                                                                                                                                                                                

  Chemical compound, drug             DPX Mountant for histology                              Sigma-Aldrich                                                              DPX Mountant for histology:06522--100 ML                                                                                                 

  Chemical compound, drug             ProLong Gold Antifade Mountant with DAPI                Invitrogen                                                                 ProLong Gold Antifade Mountant with DAPI: P36931                                                                                         

  Chemical compound, drug             Trizol                                                  Invitrogen                                                                 TRIzol Reagent:15596026                                                                                                                  

  Chemical compound, drug             FACSmax cell disassociation solution                    Genlantis                                                                  FACSmax Cell Dissociation Solution: AMS.T200110                                                                                          

  Chemical compound, drug             OCT compound Tissue-Tek                                 Sifam Instruments LTD                                                      OCT COMPOUND TISSUE-TEK: SIFAAGR1180                                                                                                     

  Chemical compound, drug             Nystatin                                                Sigma-Aldrich                                                              Nystatin powder, BioReagent, suitable for cell culture: N6261-500KU                                                                      

  Software, algorithm                 Color Inspector 3D                                      ImageJ 1.51 n plugin                                                       RRID:[SCR_002285](https://scicrunch.org/resolver/SCR_002285)                                                                             

  Software, algorithm                 Fiji                                                    ImageJ 1.51 n                                                              RRID:[SCR_002285](https://scicrunch.org/resolver/SCR_002285)                                                                             

  Software, algorithm                 Feature Extraction Software                             Agilent Technologies                                                       RRID:[SCR_014963](https://scicrunch.org/resolver/SCR_014963)                                                                             

  Software, algorithm                 Rsubread package                                        R-3.3.3; [@bib31]. DOI: 10.1093/nar/gkt214                                 RRID:[SCR_009803](https://scicrunch.org/resolver/SCR_009803)                                                                             

  Software, algorithm                 SCDE                                                    [@bib25] DOI:10.1038/nmeth.2967                                            RRID:SCR_015952                                                                                                                          

  Software, algorithm                 SC3 package                                             [@bib28] DOI: 0.1038/nmeth.4236                                            RRID:SCR_015953                                                                                                                          

  Software, algorithm                 Scater package                                          [@bib37] DOI:10.1093/bioinformatics/btw777                                 RRID:SCR_015954                                                                                                                          

  Software, algorithm                 STAR RNA-seq aligner                                    [@bib10] DOI: 10.1093/bioinformatics/bts635                                RRID:SCR_015899                                                                                                                          

  Software, algorithm                 FACSDiva software                                       Version 6.1.3; BD Biosciences                                              RRID:[SCR_001456](https://scicrunch.org/resolver/SCR_001456)                                                                             

  Software, algorithm                 Webgestalt                                              [@bib56] DOI: 10.1093/nar/gkt439                                           RRID:[SCR_006786](https://scicrunch.org/resolver/SCR_006786)                                                                             

  Software, algorithm                 Rosetta Resolver gene expression data analysis system   Rosetta Biosoftware                                                        RRID:[SCR_008587](https://scicrunch.org/resolver/SCR_008587)                                                                             

  Other                               Alizarin Red                                            Fisher Scientific                                                          Alizarin Red S Sodium Salt25G:11329707                                                                                                   

  Other                               Alcian Blue                                             Sigma                                                                      Alcian Blue 8Gx: A5268-10G                                                                                                               
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Zebrafish lines {#s4-1}
---------------

All experimental procedures were approved by the University of Edinburgh Ethics Committee and were in accordance with the UK Animals (Scientific Procedures) Act 1986. Transgenic lines for this study include: *Tg(entpd5a:pkRed)* ([@bib21])*, Tg(SAGFF214A:GalFF;UAS:gfp)* ([@bib60]), *Tg(wt1a:gfp)* ([@bib5]), *Tg(wt1b:gfp)* ([@bib5]; [@bib43]). Many of the studies were performed in a transparent background created by crossing homozygous *Tg(wt1b:gfp)* fish to homozygous pigment-free transparent *casper* fish ([@bib58]). The *Tg(wt1b:gfp;R2col2a1a:mCherry)* line was created by injecting the *R2col2a1a:mCherry* construct ([@bib8]) with a Tol2 transposase ([@bib24]) into *Tg(wt1b:gfp;casper*) zebrafish embryos, generating *Tg(R2col2a1a:mCherry)^ue401Tg^*.

Notochord needle injury and tail amputation assays {#s4-2}
--------------------------------------------------

For notochord wounds on day 3, larvae were anaesthetised in tricaine, placed sagittally on a petri dish and either inserted gently with an electrolysis-sharpened tungsten wire or tail amputated at different levels. Injured larvae were transferred to fresh water to recover and observe. Non-injured age-matched larvae were grown as non-injured controls. For injuries on day 5 and 7 pf larvae, the notochord wounds were generated using stainless steel insect pins (0.10 mm), under fluorescence light in a Leica (Germany) M165FC with a 1.0X plan Apo objective. All pictures (brightfield, Kaede and alizarin red stains) where taken using an Olympus (Japan) szx16 with a 1.5X Plan Apo objective with a Leica DFC 450C camera.

Whole-mount microscopy {#s4-3}
----------------------

Live and fixed whole-mount time-course and time-lapse experiments were performed using an AZ100 upright macroscope (Nikon; Japan) using a x2 and x5 lens with a Retiga Exi camera (Qimaging) or Coolsnap HQ2 camera (Photometrics; Tucson, Arizona) or a Leica MZFLIII fluorescence stereo microscope fitted with a Qimaging Retiga Exi camera. Images were analyzed and processed using the IPLab Spectrum and Micro-Manager software. Live and fixed whole-mount confocal imaging was performed using an A1R confocal system (Nikon) using x10 and a x20 lens over a Z-plane range of 80--100 μm (approximate width of the notochord) using a 480 nm laser (GFP), a 520 nm (RFP) and/or a 561 nm laser (alizarin red). Images were captured and analysed using Nis-Elements C software (Nikon). Images of the nystatin-treated larvae were acquired by using a 20x lens on the Imaging Platform Dragonfly (Andor Technologies, Belfast UK) with 488 nm (GFP) and 561 nm (RFP) lasers built on a Nikon TiE microscope body with a Perfect focus system (Nikon Instruments). Z stacks through the notochord were collected in Spinning Disk 25 μm pinhole mode on the Zyla 4.2 camera using a Bin of 1 and frame averaging of 1 using Fusion v1.4 software. Data were visualised using Fiji, and histograms generated using its Color Inspector 3D plugin. Multiphoton confocal time-lapse imaging was performed using an SP5 confocal microscope (Leica) equipped with a Ti:Sapphire multiphoton laser (Spectra Physics; Santa Clara, California) and a three axis motorised stage. For confocal imaging and time-lapse experiments, anaesthetised injured and non-injured larvae were embedded sagittally in a drop of 1% low-melting point agarose prior to imaging, in a specially designed glass insert, which was covered in a mixture of E3 medium and anaesthetic. All time-lapse imaging was done at 30 or 60- min intervals over 48 hr using an incubation chamber (Solent Scientific; UK) under a constant temperature of 28°C and larvae were terminated in an overdose of tricaine at the end of each experiment.

Histology {#s4-4}
---------

Zebrafish larvae younger than 20 dpf were culled and fixed overnight in 4% PFA/PBS at 4°C. The fixed larvae were washed in PBS, dehydrated in rising methanol/PBS concentrations and cleared in xylene before being paraffin embedded for sectioning. Older zebrafish were culled and fixed in 4% PFA/PBS at 4°C for 3 days with an abdominal incision to ensure tissue penetrance of the fixative ([@bib55]; [@bib59]). Fish were decalcified using 0.5M EDTA (pH 7.5) for 5 days in a rocker at 4°C and dehydrated in 70% ethanol at 4°C. Fish were embedded in paraffin using a Miles Scientific Tissue TEK VIP automated processor. Embedded larvae and older zebrafish were sectioned using a Leica RM2235 rotary microtome to a width of 5 μm. Sections were haematoxylin and eosin (H and E) stained and mounted using DPX mountant for histology (Sigma-Aldrich; St. Louis, Missouri). For cryosections, zebrafish larvae were embedded in OCT compound Tissue Tek (Sifam Instruments LTD; UK) and cut to 8 μm following protocols available at [www.zfin.org.](http://www.zfin.org.)

Wt1 zebrafish antibody {#s4-5}
----------------------

The Wt1 antibody was synthesised by Cambridge Research Biochemicals (CRB; UK) antibody production services ([http://www.crbdiscovery.com/home](http://www.crbdiscovery.com)). The antibody was created using the CRB TARGET antibody production protocol (<https://www.crbdiscovery.com/antibodies/target-antibodies/>), which used a HPLC-purified peptide made from the third zinc finger domain of zebrafish Wt1 (CQRKFSRSDHLKTHTRT) to immunise two rabbits. This epitope is found in both Wt1a and Wt1b, and the antibody is expected to detect both zebrafish Wt1a and Wt1b. The serum from each rabbit was collected at multiple time points and tested for the presence of Wt1 antibodies using an electrophoretic mobility shift assay (EMSA). The purified polyclonal antibody was extracted from the rabbit serum on the final collection day. Western blot analysis of lysates from zebrafish (24 hpf) revealed a strong band at approximately 45 kDa, consistent with the size of zebrafish Wt1a/b protein. Immunofluorescence on paraffin-embedded sections with Wt1 antibody (diluted 1:33,000) revealed cell-specific staining in the kidney and notochord wound site that was depleted by co-incubation of the Wt1 antibody with the Wt1 epitope peptide.

Immunohistochemistry {#s4-6}
--------------------

Slides were de-waxed in xylene and rehydrated through decreasing ethanol washes, before being incubated in a bleach solution to remove pigment. Antigen-unmasking was performed as previously described ([@bib42]). with the Dako REAL EnVision Detection System kit (Dako; UK) following manufacturer's instructions. Slides were incubated overnight at 4°C with the following antibodies: anti-rabbit α-GFP (1:1,500; Cell Signaling Technology) and anti-rabbit α-WT1 (1:25,000; Cambridge Research Biochemicals; UK). An Axioplan II fluorescence microscope (Zeiss; Germany) with a Plan Apochromat objective was used for brightfield imaging of tissue sections. Images were captured using a Qimaging Micropublisher 3.3mp cooled CCD camera and analysed using the IPLab Spectrum software.

Immunofluorescence {#s4-7}
------------------

Slides were processed as described above and blocked in 10% heat inactivated donkey serum for 2 hr. Slides were incubated overnight at 4°C with α-WT1 (1:33,000) antibody diluted in 1% heat inactivated donkey serum in TBSTw. Slides were incubated for 1 hr in a secondary anti-rabbit AlexaFluor 488 antibody (1:800) (Invitrogen; Carlsbad, California) in 1% heat inactivated donkey serum and mounted in ProLong Gold Antifade Mountant with DAPI (Invitrogen) overnight before being imaged in a fluorescent stereomicroscope.

Tissue staining {#s4-8}
---------------

Live bone staining was performed using 0.2% (w/v) calcein or using 50 μg/ml alizarin red (Fisher Scientific; UK) as previously described ([@bib26]). For cartilage and bone staining, we used alcian blue and alizarin red following the protocol outlined in ([@bib55]) with modifications from protocols on [www.zfin.org.](http://www.zfin.org.) Bone and cartilage staining in fixed larvae was performed on PFA fixed and then methanol dehydrated specimens, treated overnight at 4°C with 0.02% (weight to volume) alizarin red in 70% ethanol. Specimens were bleached (H~2~O~2~) and cleared before storing in glycerol for imaging.

RNA extraction and microarray analysis {#s4-9}
--------------------------------------

*Tg(wt1b:gfp)* zebrafish larvae were needle injured and grown to 72 hpi with age-matched non-injured controls. The area around the site of injury was dissected and transferred into 1 ml of chilled RNA-later. The samples were centrifuged into a pellet at 4°C and macerated in 500 μl of Trizol (Invitrogen) using a 25G ^5/8^1 ml syringe. RNA was extracted following Trizol manufacturer's instructions and eluted into 15 μl of distilled H~2~O. Extracted RNA was sent to Myltenyi Biotec (Germany) who conducted the microarray analysis. Injured and non-injured samples were sent in triplicates and the RNA was amplified and Cy3-labelled using a Low Input Quick Amp Labelling Kit (Agilent Technologies; UK) following manufacturer's instructions. The labelled cRNA was hybridised against a 4 × 44K Whole Zebrafish (V3) Genome Oligo Microarray (Agilent Technologies). The microarray images were processed using the Feature Extraction Software (FES -- Agilent Technologies) and differential gene expression was determined using the Rosetta Resolver gene expression data analysis system (Rosetta Biosoftware).

Fluorescence-Activated cell sorting {#s4-10}
-----------------------------------

The trunk region of fifty *Tg(wt1b:gfp; R2col2a1a:mCherry)* injured larvae and non-injured 72 hpi larvae were dissected and collected separately in cold PBS + 2% fetal calf serum (FCS). Tissue disassociation was adapted from a previously described protocol ([@bib35]) and centrifuged cells were collected in FACSmax cell disassociation solution (Genlantis; San Diego, California). The samples were passed twice through a 40 μm cell strainer, collected in an agar-coated petri dish on ice and transferred into an eppendorf tube to be sorted by a FACSAria2 SORP instrument (BD Biosciences; UK) equipped with a 405 nm, a 488 nm and a 561 nm laser. Green fluorescence was detected using GFP filters 525/50 BP and 488 nm laser, red fluorescence was detected using 585/15 BP filter and 561 nm laser. Data were analysed using FACSDiva software (BD Biosciences) Version 6.1.3. For single cell sequencing, single cell or 10 cells were sorted into 96-well plates; for quantitive realtime PCR (qPCR) analysis, cells were collected by centrifuging at 6000 rpm for 5 min.

*wt1b* mutant line {#s4-11}
------------------

The *wt1b* genetic mutant line was generated by CRISPR/Cas9 with a guide RNA target GGTCAGACCTGGAGAAGCGG (on the reverse strand) in the exon of *wt1b* that encodes zinc finger 2. Crispr/Cas9 genome editing was carried out following the Joung lab protocol ([@bib22]), with injection of a zebrafish codon optimized Cas9 mRNA ([@bib23]). Two founders carrying germline mutations at the target site were identified: one mutation is a deletion of 12 bp (leading to an in-frame deletion) and the other is a deletion of 5 bp (*wt1b^∆5^*)*^ue402^*, and was used in this study.

qRT-PCR analysis {#s4-12}
----------------

RNA extraction, in vitro synthesis and PCR amplification of cDNA were performed using the Smart Seq2 protocol ([@bib45]). Amplified cDNA was quantified using a bioanalyzer, and directly used for qRT-PCR without further dilution of the cDNA template. qPCR was performed in a Roche LightCycler480 using a SYBR green protocol. ∆Ct (the difference between the cycle threshold (Ct) value of the gene of interest and the Ct value of *ß-actin* or *gapdh*) was used to compare the expression level of genes. Statistics (St Dev and paired T-test) were performed using Matlab (Natick, Massachussets). Primers are listed in [Supplementary file 2](#supp2){ref-type="supplementary-material"}.

Single-cell and 10 cell sequencing {#s4-13}
----------------------------------

RNA extraction, in vitro synthesis and PCR amplification of cDNA, and construction of a sequencing library using the Nextera XT DNA Library Preparation Kit (Illumina; San Diego California) according to the Smart Seq2 protocol with minor modifications as described before ([@bib45]). Libraries were sequenced on a NextSeq Illumina sequencer. Reads were mapped against the Ensembl *Danio rerio* reference genome version GRCz10.90 ([@bib13]) with the inclusion of the reference for the spike in controls from the ERCC consortium, as well as the coding sequence for EGFP and mCherry, using STAR RNA-seq aligner ([@bib10]). For quality control and pre-processing, quantification of mapped reads per gene was calculated using the Rsubread package in R-3.3.3 ([@bib31]). Genes that were not expressed in any cells were excluded. The gene counts were loaded as a scater object in R-3.3.3 (using the scater package) and standard quality control metrics were calculated ([@bib37]). Quality control exclusion criteria were cells with more than 25% of reads mapping to ERCCs or fewer than 100,000 reads or fewer than 1000 genes detected (at least one read per gene) were rejected (see [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} and [Supplementary file 1a](#supp1){ref-type="supplementary-material"}).

Consensus clustering set to three clusters was conducted on the single and 10 cells using the SC3 package ([@bib28]). The 10 cell group was isolated and SC3 consensus clustering set to three clusters was conducted on these cells alone. Differential expression between cluster 2 and cluster 3 of the SC3 10 cell analysis was conducted using SCDE ([@bib25]). A differential expression list, ranked from cluster 2 to cluster three according to z-score was used for the GSEA analysis ([@bib39]; [@bib52]). The differential expression list was tested against gene lists compiled from online resources ([Supplementary file 1b](#supp1){ref-type="supplementary-material"}). Functional analysis between the ranked 10 cell list and online gene lists for gene ontology (biological processes, non-redundant) and pathways (KEGG, Panther, Reactome and WikiPathway databases were used) using the online tool WebGestalt and gene set enrichment function ([@bib56]).

Vertebrae size measurements and statistical analysis {#s4-14}
----------------------------------------------------

The vertebrae size difference in injured zebrafish larvae (age range 30 dpi to 38 dpi) were compared between vertebrae at the site of injury (injured) and vertebrae outside of the site of injury (uninjured). Injured vertebrae and uninjured vertebrae were measured and the average length was recorded for each group. The average lengths were then compared and the relative size difference was calculated. The relative size difference between each group (injured:uninjured vs. uninjured:uninjured) was compared using an unpaired t-test.
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Decision letter

Bagnat

Michel

Reviewing Editor

Duke University

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"*Wilms Tumor 1b* defines a wound-specific sheath cell subpopulation associated with notochord repair\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Guest Reviewing Editor and Didier Stainier as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

All three reviewers agreed the manuscript reports an interesting phenomenon that adds new perspectives beyond recently published work by Garcia et al. and that the paper is well presented. The reviewers also pointed out the somewhat descriptive nature of the study in its present form and the need to strengthen key observations. Particularly, the significance of *wt1b* induction, which is the foundation of the whole paper. There was also interest from all in the formation of ectopic vertebrae, potentially via a cartilage intermediate, which is an intriguing possibility that also needs to be substantiated further. Finally, there were also two specific points raising the need for better characterization of the injury model and the regenerative response.

Essential revisions:

1\) The emergence of a *wt1b*+ positive cell population that is otherwise not detectable within the developing or mature notochord is supported solely by the use of *Tg(wt1b:GFP)* transgene, the conclusions of the paper would be strengthened by showing that the transgene faithfully recapitulates endogenous *wt1b* expression.

1a) Are *wt1b* mRNA and/or protein excluded from the uninjured, developing notochord?

1b) Is induction of *wt1b* mRNA restricted to the injury site as shown by the transgenic reporter?

2\) The significance of *wt1b* induction was not addressed experimentally. Ideally, the authors should attempt a loss of function using a *wt1b* mutant, or a *wt1b*:Nitroreductase cell ablation approach. Alternatively, a gain of function experiment driving *wt1b* mosaically from the *col2* promoter may prove revealing.

3\) As stated by the authors, in the heart *wt1b* expression is linked to EMT. Is this also the case in the injured notochord?

4\) The authors state that they do not see vacuolated *wt1b* expressing cells at the site of injury, suggesting there are two genetically distinct sheath populations that are involved in different aspects of repair. Were the *wt1b/col2a1a* reporter fish presented in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} followed over to determine whether *col2a1a* positive / *wt1b* negative cells become vacuolated at the site of injury?

5\) Is *wt1b* induced in sheath cells following vacuolated cell ablation (e.g. genetic ablation using SAG214:Gal4 and UAS:NTR)? This would determine whether *wt1b* induction is specific to injuries that breach the notochord sheath or not.

6\) Given that multiple cell types contribute to centra development, it is unclear in this report where the cartilage forming cells are derived following injury. It is also unclear whether the cartilage that is rapidly observed after injury is directly giving rise to the centrum that later forms at that site. To address these points, at least partially, the authors should perform whole mount in situ hybridization with sclerotome markers and some of the top cartilage hits from the RNA-seq dataset.

7\) The authors state that one extra vertebra forms at the site of injury (albeit smaller than normal). The authors should provide some more details about this phenotype, particularly regarding the variability of extra vertebrae. The damage from the injury could cause a single centrum precursor population to be split into two, resulting in the formation of two small centra and an extra vertebra. If the damage occurs at the natural border between two centra, the split in the precursor population would not occur and there would be no extra vertebra. The data in [Figure 4E](#fig4){ref-type="fig"} shows that the extra vertebra is smaller in size, and it also appears in [image 4D](#fig4){ref-type="fig"} that the vertebra adjacent to the ectopic vertebra is also smaller in size. This seems to suggest that an original centrum population is being split into two smaller populations and would imply a wound healing process rather than de novo generation/regeneration of a precursor population. In addition, they should use Safranin-O staining in sections during supernumerary vertebrae formation to better support their conclusions.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"*Wilms Tumor 1b* defines a wound-specific sheath cell subpopulation associated with notochord repair\" for further consideration at *eLife*. Your revised article has been favorably evaluated by a Guest Reviewing Editor and Didier Stainier as Senior Editor.

The authors were fully responsive to the critiques raised by three reviewers and made substantial improvements to their original manuscript which resulted in a much-improved story. There is however one issue detailed below arising from the revised work that needs to be corrected before this manuscript is accepted for publication. There are also small editorial changes and corrections that need to be made. These corrections require in principle only editorial changes.

Main correction:

1\) Nystatin cannot be considered a caveolin inhibitor or an inhibitor of caveolae-mediated endocytosis, even if this erroneous assumption is perpetuated in some journals. This does not preclude that nystatin may cause vacuolated cell collapse but cannot be attributed to the inhibition of caveolae. Provided the authors are confident the sheath is not breached under their experimental conditions, the text could be revised to introduce corrections along the lines shown below. Alternatively, the authors may choose to use EM to determine whether treatment with nystatin indeed causes loss of caveolae or assay a function that is unequivocally caveolae dependent.

Text revision:

Subsection title: should be changed to remove the definition of nystatin as a caveolin inhibitor, e.g. \"Vacuolated cell collapse leads to an increase in *wt1b:gfp* expression\", \"Nystatin mediated disruption of vacuolated cells leads to an increase in *wt1b:gfp* expression\", or something to that effect.

Text: the references to nystatin as a caveolin or caveolae inhibitor should be removed. Instead the authors may report the (specific?) effect of nystatin in vacuolated cells and mention its \"similarity\" to the phenotype of caveolin mutants. Using the term phenocopy would imply that other aspects of the phenotype are also recapitulated, which was not examined in this work. As long as the sheath is not breached the conclusions would remain the same.

2\) The reference to the manuscript by Lleras et al. should be expressed as personal communication instead of \"submitted\" at this point. This might be updated later depending on the timing of publication.

Additional points:

Subsection "Wound specific expression of *wt1b* in the notochord", last paragraph: It would be better to say: \"to induce localized damage\" instead of \"to specifically induce localized damage\". The word \"specifically\" would not be appropriate for this type of injury.

Subsection "*wt1b* expressing cells emerge from the notochord sheath", first paragraph: *Tg(SAGFF214A:gfp)* labels the cytoplasm of vacuolated cells, not the membrane. Please correct.

Is the signal for the *wt1* antibody lost in the *wt1b* mutant? Please clarify in the text if appropriate and include as much information as possible about this original reagent.

10.7554/eLife.30657.029

Author response

> Summary:
>
> All three reviewers agreed the manuscript reports an interesting phenomenon that adds new perspectives beyond recently published work by Garcia et al. and that the paper is well presented. The reviewers also pointed out the somewhat descriptive nature of the study in its present form and the need to strengthen key observations. Particularly, the significance of wt1b induction, which is the foundation of the whole paper. There was also interest from all in the formation of ectopic vertebrae, potentially via a cartilage intermediate, which is an intriguing possibility that also needs to be substantiated further. Finally, there were also two specific points raising the need for better characterization of the injury model and the regenerative response.

We now add substantial new data to our manuscript to address all seven essential revisions. To summarize the changes we have made, we would like to highlight the following major new revisions to our work:

1\) Significance of the *wt1b* induction. We have now proved Wt1b protein and *wt1b* gene expression specifically at the site of injury in the notochord, and we have generated and characterised a *wt1b* mutant line. (Essential revisions 1, 2).

2\) Further substantiation of the formation of the *wt1b*-expressingvertebrae. We present new single-cell and 10-cell sequencing studies in the zebrafish notochord, and together with validated gene expression array data comparing injured and control regions, provide strong evidence that the *wt1b*+ sheath cells express cartilage and vacuolar cellular pathways, and represses a novel Wt1b-p53 transcriptional programme. These *wt1b*-expressing cells are maintained within the injured vertebrae until adulthood. (Essential revisions 3, 4, 6).

3\) Better characterization of the injury model and regenerative response. We have now better characterized the injury model by applying a Caveolin inhibitor to phenocopy the *caveolin* zebrafish mutants and reveal *wt1b+* subpopulations to emerge with and without breach of the sheath. Furthermore, and following an insightful suggestion from one reviewer, we have found that the site of injury does impact upon the final vertebrae number and suggest that the appearance of *wt1b:gfp* cells that stay closely associated with the adult vertebrae at the site of damage reflect a wound healing process. (Essential revisions 5, 7).

> Essential revisions:
>
> 1\) The emergence of a wt1b+ positive cell population that is otherwise not detectable within the developing or mature notochord is supported solely by the use of Tg(wt1b:GFP) transgene, the conclusions of the paper would be strengthened by showing that the transgene faithfully recapitulates endogenous wt1b expression.
>
> 1a) Are wt1b mRNA and/or protein excluded from the uninjured, developing notochord?
>
> 1b) Is induction of wt1b mRNA restricted to the injury site as shown by the transgenic reporter?

Thank you for this critical comment to address the endogenous expression of *wt1b* in the zebrafish notochord. We do already present evidence of endogenous Wt1b protein expression in [Figure 1E](#fig1){ref-type="fig"}. We have generated our own antibody toward zebrafish Wt1 and show that it is expressed at the damage site ([Author response image 1](#respfig1){ref-type="fig"}).

![](elife-30657-resp-fig1){#respfig1}

Building on this, we now include immunohistochemistry of notochord sections stained with anti-GFP and anti-WT1 antibodies in injured and non-injured fish (new [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). This demonstrates that GFP and Wt1b protein is restricted to the injury site in the notochord, and excluded from the uninjured, developing notochord.

Further, we now provide evidence of endogenous *wt1b* mRNA expression in *wt1b:gfp* -positive cells.As described in more detail below, we have now added new data of single-cell and 10-cell sequencing of FACS sorted cells from the injured *Tg(wt1b:gfp; col2a1a:mCherry)* zebrafish. We find *wt1b* is expressed only in cells that express *gfp* or both *gfp* and *mCherry* but find no *wt1b* expression in the cells that express *mCherry* alone (new [Figure 4B](#fig4){ref-type="fig"}).

Our antibody and RNA sequencing of sorted cells proves that the transgene faithfully recapitulates endogenous *wt1b* expression in the notochord. Our work proves that *wt1b* expression marks a unique subpopulation in notochord sheath cells following injury in zebrafish.

> 2\) The significance of wt1b induction was not addressed experimentally. Ideally, the authors should attempt a loss of function using a wt1b mutant, or a wt1b:Nitroreductase cell ablation approach. Alternatively, a gain of function experiment driving wt1b mosaically from the col2 promoter may prove revealing.

Thank you for this comment regarding the function of Wt1b in this process. We had started to generate a mutant line, with the intent to address the notochord effects in a *wt1b* mutant situation. Using CRISPR/Cas9 genome editing, we have generated a 5 bp deletion mutant line (new [Figure 8---figure supplement 1A, B](#fig8s1){ref-type="fig"}). At the time of submission, we had not had time to characterise this line. We have confirmed that only the *wt1∆5* mRNA is expressed in mutant embryos (new [Figure 8---figure supplement 1C](#fig8s1){ref-type="fig"}). We now have adult homozygous *wt1^∆5/∆5^*mutant fish and have analysed these for *wt1b:gfp* expression, cellularity at the damage site, cartilage formation at the site of injury and in the *wt1b:GFP* expressing adult vertebrae (new [Figure 8---figure supplement 1D-G](#fig8s1){ref-type="fig"}). We do not see an overt phenotype in the *wt1^∆5/∆5^*mutant. However, our new data from the single-cell and 10 cell-sequencing reveals a Wt1 transcriptional signature, coupled with the continued expression of *wt1b:gfp* up to adult stages. This suggests that Wt1 may indeed be more than a marker of sheath cell populations in a wounding response. It is possible that compensatory mechanisms exist, and indeed we find a small but significant increase in *wt1a* expression in injured tissue from the *wt1b^∆5/∆5^* mutants. We now include a section on this in the Discussion.

> 3\) As stated by the authors, in the heart wt1b expression is linked to EMT. Is this also the case in the injured notochord?
>
> 4\) The authors state that they do not see vacuolated wt1b expressing cells at the site of injury, suggesting there are two genetically distinct sheath populations that are involved in different aspects of repair. Were the wt1b/col2a1a reporter fish presented in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} followed over to determine whether col2a1a positive / wt1b negative cells become vacuolated at the site of injury?

Thank you for these important questions. We address reviewer comments 3 and 4 together for ease of discussion.

We are also very excited to understand the nature of the *wt1b:gfp; col2a1a:mCherry* cells. To address this in an unbiased fashion, we have now performed single and 10-cell sequencing of FACS sorted cells from *Tg(wt1b:gfp; col2a1a:mCherry)* zebrafish 3 days following injury.

This is now presented in a new [Figure 4](#fig4){ref-type="fig"}. The key findings from this experiment are:

1\) The *gfp (wt1b+), mCherry (col2a1a+)* and *gfp,mCherry (wt1b+, col2a1a+)* cells independently cluster into three distinct cell subpopulations of the injured notochord (new [Figure 4A, C, C](#fig4){ref-type="fig"}). This is strong evidence that the transgenic makers reveal true cellular subpopulations in vivo.

2\) We do not find evidence of EMT at this stage, but rather observe that the *wt1b+col2a1a+* cell cluster expresses genes that are enriched for genes associated with lysosomes and vacuoles (new [Figure 4E](#fig4){ref-type="fig"}), and cartilage genes (new [Figure 4D, G](#fig4){ref-type="fig"}). This suggests that some of these cells may become vacuolated cells, and we find evidence of this when imaging larvae following injury at a later stage (new [Figure 4F](#fig4){ref-type="fig"}).

3\) The *wt1b+ col2a1a+* cell cluster is significantly associated with repression of Wt1 regulated genes (new [Figure 4H](#fig4){ref-type="fig"}). Wt1 can function as a transcriptional activator or repressor, and our evidence suggests that Wt1b may function as a repressor for a gene subset in *wt1b+ col2a1a+* cells.

4\) Wt1 function is regulated by interactions with transcription co-factors that enable activation or repression of target genes. We screened the *wt1b+ col2a1a+* cell cluster for selective enrichment of Wt1 co-factors and found *tp53* expression specifically enriched in the *wt1b+ col2a1a+* cell cluster (new [Figure 4I, J](#fig4){ref-type="fig"}). Remarkably, a p53 gene set enrichment analysis (GSEA) reveals that p53 genes are significantly enriched in the *wt1b+ col2a1a+* cell cluster (new [Figure 4K](#fig4){ref-type="fig"}). However, genes co-regulated by Wt1 and p53 are selectively repressed in the *wt1b+ col2a1a+* cell cluster (new [Figure 4L](#fig4){ref-type="fig"}). This was completely unexpected and reveals a novel and unknown Wt1-p53 axis that may function together in the notochord wound process.

> 5\) Is wt1b induced in sheath cells following vacuolated cell ablation (e.g. genetic ablation using SAG214:Gal4 and UAS:NTR)? This would determine whether wt1b induction is specific to injuries that breach the notochord sheath or not.

We appreciate that the *Tg(SAG214A:Gal4; USA:NTR)* approach would be informative, however, we do not have the combination of these transgenic lines in house, and to obtain them would have required to cross two different transgenes onto the *Tg(wt1b:gfp)* transgenic background (two generation times plus shipping of animals between different sites).

Instead, we have tried to phenocopy the *cav1* mutant phenotypes (Garcia et al., 2017). In our first attempts, we used a morpholino and a crispant approach to target *cav1*, but we were unable to see the altered cellularity at the notochord site.

As an alternative approach, we used a small molecule caveolin inhibitor called Nystatin ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Nystatin binds sterols and inhibits caveolae-mediated endocytosis. Remarkably, treatment of *Tg(wt1b:gfp; col2a1a:mCherry)* zebrafish with nystatin showed a dose-dependent increase in cellularity in the notochord, similar to *cav1, cav3* and *cavin1b* mutants. GFP was strongly expressed in a subpopulation of the mCherry-positive sheath cells (white arrows), and cells expressing both *gfp* and *mCherry* were clearly visible at the site of cellularity (yellow arrows).

Our work now shows that *wt1b* expression defines the subpopulation of sheath cells that fill gaps in the vacuolated notochord following the breach of the notochord sheath and following notochord vacuolar dysfunction. We are excited that our work is applicable to the conditions of vacuolated cell damage and have included this data in the Results and Discussion sections.

> 6\) Given that multiple cell types contribute to centra development, it is unclear in this report where the cartilage forming cells are derived following injury. It is also unclear whether the cartilage that is rapidly observed after injury is directly giving rise to the centrum that later forms at that site. To address these points, at least partially, the authors should perform whole mount in situ hybridization with sclerotome markers and some of the top cartilage hits from the RNA-seq dataset.

We agree that this is an interesting question, but since the (chorda)centrum is an acellular structure, it is not possible to show which cells contribute to it, at least during the first steps of mineralisation and before any osteocytes appear (which is much later). However, since *entpd5* is essential for mineralization and since we see *entpd5a*+ notochord sheath cells in the wound area, it seems likely that sheath cells, in conjunction with cartilage formation at the site of injury play a critical role in centrum formation. We have extended the Discussion accordingly to discuss this point in more detail.

In further response to this question, we have isolated sections of the damage site and control undamaged tissue and performed qRT-PCR for the *matrix gla protein* (*mgp)* and *Sox9* mRNA expression. We chose these two genes because *mgp* was highly expressed in the microarray analysis and important for bone organisation, and because Sox9b is a master cartilage transcription factor. Our new findings demonstrate that *mgp* RNA is increased in notochord damaged tissue, compared with undamaged notochord tissue ([Figure 3F, G](#fig3){ref-type="fig"}). This validates the microarray analysis and supports the wound specific upregulation of cartilage genes.

To address which cells in the wound response express the cartilage genes, we have isolated FACS sorted cells from Tg(*wt1b:gfp; col2a1a:mCherry)* injured fish and find *sox9b* and *mgp* to be selectively upregulated in the GFP^+^mCherry^+^ cell populations([Figure 4D](#fig4){ref-type="fig"}).These findings indicate that the *wt1b*-positive sheath cells express the cartilage genes and may co-ordinate the cartilage response at the wound site.

> 7\) The authors state that one extra vertebra forms at the site of injury (albeit smaller than normal). The authors should provide some more details about this phenotype, particularly regarding the variability of extra vertebrae. The damage from the injury could cause a single centrum precursor population to be split into two, resulting in the formation of two small centra and an extra vertebra. If the damage occurs at the natural border between two centra, the split in the precursor population would not occur and there would be no extra vertebra. The data in [Figure 4E](#fig4){ref-type="fig"} shows that the extra vertebra is smaller in size, and it also appears in [image 4D](#fig4){ref-type="fig"} that the vertebra adjacent to the ectopic vertebra is also smaller in size. This seems to suggest that an original centrum population is being split into two smaller populations and would imply a wound healing process rather than de novo generation/regeneration of a precursor population. In addition, they should use Safranin-O staining in sections during supernumerary vertebrae formation to better support their conclusions.

We thank the reviewers for their insightful question regarding the possibility that we are damaging a precursor population upon injury. At 3 dpf, we do not have a means to visualise a centrum precursor population, however, by day 5 and 7 pf we can visualize the patterned expression of *entpd5a* in the notochord using Tg(*entpd5a:kaede*). New evidence demonstrates that metameric expression of *entpd5a* in notochord sheath cells is an essentialrequirement for the patterned formation of chordacentra rings (Lleras Forero et al., submitted). Indeed, the reviewer is correct, and we find that the extra vertebrae is present only upon damaging an *entpd5a* expression domain (new [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). This indicates that the wound response alone is not sufficient to induce an extra vertebra, and that *entpd5a* cell population domains are likely to be important in the vertebra formation at the wound site.

Nonetheless, we consistently find that the vertebra(e) that forms at the site of the damage is/are significantly smaller in a given space interval and have quantified this ([Figure 5E](#fig5){ref-type="fig"}). Further, we find it remarkable that the *wt1b:gfp* response is long-lasting over time, and that *wt1b:gfp* expressing cells remain associated with the vertebra(e) at the damage site. To address this phenomenon, we have been able to improve our confocal imaging of Tg(*wt1b:gfp*) and alizarin staining in live adult fish (new [Figure 7G](#fig7){ref-type="fig"}) and continue to observe *wt1b:gfp* expressing cells associated with the single vertebra or two vertebrae at the site of damage until adulthood, and (at least one of) these vertebrae are smaller. We have now amended the text and [Figure 7](#fig7){ref-type="fig"} (previous [Figure 6](#fig6){ref-type="fig"}) to incorporate this change and emphasise what we believe are the first steps to understanding this important wound-healing process.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> The authors were fully responsive to the critiques raised by three reviewers and made substantial improvements to their original manuscript which resulted in a much-improved story. There is however one issue detailed below arising from the revised work that needs to be corrected before this manuscript is accepted for publication. There are also small editorial changes and corrections that need to be made. These corrections require in principle only editorial changes.
>
> Main correction:
>
> 1\) Nystatin cannot be considered a caveolin inhibitor or an inhibitor of caveolae-mediated endocytosis, even if this erroneous assumption is perpetuated in some journals. This does not preclude that nystatin may cause vacuolated cell collapse but cannot be attributed to the inhibition of caveolae. Provided the authors are confident the sheath is not breached under their experimental conditions, the text could be revised to introduce corrections along the lines shown below. Alternatively, the authors may choose to use EM to determine whether treatment with nystatin indeed causes loss of caveolae or assay a function that is unequivocally caveolae dependent.
>
> Text revision:
>
> Subsection title: should be changed to remove the definition of nystatin as a caveolin inhibitor, e.g. \"Vacuolated cell collapse leads to an increase in wt1b:gfp expression\", \"Nystatin mediated disruption of vacuolated cells leads to an increase in wt1b:gfp expression\", or something to that effect.

Thank you, as suggested, this has now been changed to: "Nystatin mediated disruption of vacuolated cells leads to an increase in *wt1b:gfp* expression".

> Text: the references to nystatin as a caveolin or caveolae inhibitor should be removed. Instead the authors may report the (specific?) effect of nystatin in vacuolated cells and mention its \"similarity\" to the phenotype of caveolin mutants. Using the term phenocopy would imply that other aspects of the phenotype are also recapitulated, which was not examined in this work. As long as the sheath is not breached the conclusions would remain the same.

Thank you, this text now reads:

"Nystatin mediated disruption of vacuolated cells leads to an increase in *wt1b:gfp* expression

We tested if the *wt1b*-response was specific to wounds that involved rupture of the sheath, or if *wt1b* expressing cells could be induced upon loss of vacuolated cell integrity alone. \[...\] Thus, expression of *wt1b* in the sheath does notrequire a physical breach of the sheath, and *wt1b* expression may be applicable to a wider range of tissue stress and damage situations."

We have also changed the heading of [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"} to read:

"[Figure 2 ---figure supplement 2](#fig2s2){ref-type="fig"}. Nystatin treatment leads to upregulation of *wt1b:gfp* expression in notochord sheath cells".

> 2\) The reference to the manuscript by Lleras et al. should be expressed as personal communication instead of \"submitted\" at this point. This might be updated later depending on the timing of publication.

Thank you, this has now been changed to LL-F and SS-M, personal communication.

> Additional points:
>
> Subsection "Wound specific expression of wt1b in the notochord", last paragraph: It would be better to say: \"to induce localized damage\" instead of \"to specifically induce localized damage\". The word \"specifically\" would not be appropriate for this type of injury.

Thank you, this has now been changed.

> Subsection "wt1b expressing cells emerge from the notochord sheath", first paragraph: Tg(SAGFF214A:gfp) labels the cytoplasm of vacuolated cells, not the membrane. Please correct.

Thank you, this is now corrected.

> Is the signal for the wt1 antibody lost in the wt1b mutant? Please clarify in the text if appropriate and include as much information as possible about this original reagent.

We have not tested the antibody on the Wt1b mutants, however please note that the antibody is raised against an epitope that is present in both Wt1a and Wt1b, so complete loss of Wt1 signal may only be detectable in a wt1a^-^wt1b^-^ double mutant, which is not available at this time.

Please find a new paragraph that has been added to the Materials and methods section with more detail about the Wt1 antibody. We tested the antibody by western blot and see a very strong band at 43kDa, consistent with the molecular weight of Wt1 proteins in zebrafish. We used a peptide competition assay by immunofluorescence to demonstrate that the antibody is highly selective for the Wt1 epitope.

"αWt1 zebrafish antibody

The Wt1 antibody was synthesised by Cambridge Research Biochemicals (CRB) antibody production services (http://www.crbdiscovery.com/home). \[...\] Immunofluorescence on paraffin-embedded sections with Wt1 antibody (diluted 1:33,000) revealed cell specific staining in the kidney and notochord wound site that was depleted by co-incubation of the Wt1 antibody with the Wt1 epitope peptide."

[^1]: These authors contributed equally to this work.
